← Back to guidelines
Cardiology12 papers

Calcification of pulmonary valve annulus

Last edited: 4/22/2026

Overview

Calcification of the pulmonary valve annulus is a condition characterized by the deposition of calcium within the annulus surrounding the pulmonary valve, often indicative of generalized atherosclerosis. While less commonly discussed than mitral annulus calcification, it shares similar clinical implications, particularly in relation to cardiovascular risk assessment.

Diagnosis

  • Echocardiography: Essential for diagnosis, particularly two-dimensional echocardiography, which accurately delineates the extent and location of calcification 2.
  • M-mode Echocardiography: Useful for identifying dense, linear echoes but limited in assessing extent 2.
  • Exclusion of Embolic Source: Important to rule out embolic stroke risk, often requiring imaging to differentiate from coexisting atherosclerosis 1.
  • Management

  • Cardiac Monitoring: Regular monitoring for associated conditions like atrial fibrillation, especially in patients with significant calcification 1.
  • Risk Factor Management: Aggressive management of cardiovascular risk factors including hypertension, hyperlipidemia, and diabetes 1.
  • No Specific Pharmacological Treatment: No specific drug class or dose is mentioned for pulmonary valve annulus calcification; focus on general cardiovascular health 12.
  • Special Populations

  • Comorbidities: Patients with significant calcification may have coexisting atrial fibrillation, increasing stroke risk 1.
  • General Considerations: No specific guidance provided for pregnancy, pediatrics, or elderly populations related to pulmonary valve annulus calcification 12.
  • Key Recommendations

  • Utilize Two-Dimensional Echocardiography for Accurate Diagnosis: Essential for assessing the extent and impact of pulmonary valve annulus calcification 2 (Evidence: Moderate).
  • Monitor for and Manage Associated Cardiac Conditions: Regularly screen for atrial fibrillation and other cardiovascular risk factors 1 (Evidence: Moderate).
  • Focus on General Cardiovascular Risk Reduction: Implement strategies to manage hypertension, hyperlipidemia, and diabetes to mitigate overall cardiovascular risk 1 (Evidence: Moderate).
  • References

    1 Furlan AJ, Craciun AR, Salcedo EE, Mellino M. Risk of stroke in patients with mitral annulus calcification. Stroke 1984. link 2 Kronzon I, Mitchell J, Shapiro J, Winer HE, Newman P. Two-dimensional echocardiography in mitral annulus calcification. AJR. American journal of roentgenology 1980. link

    Original source

    1. [1]
      Risk of stroke in patients with mitral annulus calcification.Furlan AJ, Craciun AR, Salcedo EE, Mellino M Stroke (1984)
    2. [2]
      Two-dimensional echocardiography in mitral annulus calcification.Kronzon I, Mitchell J, Shapiro J, Winer HE, Newman P AJR. American journal of roentgenology (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG